Gene · 4303
Papers2,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revealing the therapeutic potential of Laminaria japonica polysaccharides against cataract: evidence from transcriptomics, network pharmacology, and in vivo experiments. | Int Ophthalmol | 2026 | 41874747 | PubTator, text mining | PubMed |
| Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphoma. | Cell Death Dis | 2026 | 41872189 | PubTator, text mining | PubMed |
| Investigating Autophagy Genes Expression and their Possible Relations with Apoptosis in PBMCs of Patients with Thin Endometrium. | Iran J Immunol | 2026 | 41804751 | PubTator, text mining | PubMed |
| The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. | Front Oncol | 2026 | 41783438 | PubTator, text mining | PubMed |
| BioLM-NET: an interpretable deep learning model combining prior biological knowledge and contextual LLM gene embeddings on multi-omics data to predict disease. | Pac Symp Biocomput | 2026 | 41758175 | PubTator, text mining | PubMed |
| Role of Nod-like Receptors in Helicobacter pylori Infection: Insights into Innate Immune Signaling Pathways. | Microorganisms | 2026 | 41753558 | PubTator, text mining | PubMed |
| The Paradox of Senescence in Glioblastoma: SASP as an Emerging Cancer Hallmark. | Cancers (Basel) | 2026 | 41749804 | PubTator, text mining | PubMed |
| Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells. | Nat Commun | 2026 | 41723125 | PubTator, text mining | PubMed |
| 14-3-3ζ interacts with DNA-binding domain of FOXO3a and competitively dissociates DNA by dual-motif tethering. | Nat Commun | 2026 | 41699396 | PubTator, text mining | PubMed |
| Comprehensive Analysis of FOXO1 as a Tumour Suppressor Biomarker Related to Immune Infiltration and Cell Proliferation of Hepatocellular Carcinoma. | IET Syst Biol | 2026 | 41610086 | PubTator, text mining | PubMed |
| Exploring the nexus between inflammation and mobility through the lens of healthy aging: current scenario and future perspectives. | Aging Clin Exp Res | 2026 | 41609972 | PubTator, text mining | PubMed |
| RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts. | RMD Open | 2026 | 41571322 | PubTator, text mining | PubMed |
| AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape. | Nat Commun | 2026 | 41547950 | PubTator, text mining | PubMed |
| CircROR1 binds HNRNPL to regulate FOXO4 pre-mRNA splicing, promoting cutaneous melanoma metastasis and serving as a therapeutic target via RNAi-loaded PEG-LNPs. | Mol Cancer | 2026 | 41530849 | PubTator, text mining | PubMed |
| Inhibitory effect of blestriarene C on triple-negative breast cancer: Inducing ferroptosis and mitophagy via SESN2/AKT/FOXO4 axis. | Chin Med J (Engl) | 2026 | 41527177 | PubTator, text mining | PubMed |
| FOXO4 Facilitates Diabetic Retinopathy by Mediating KLF7 Transcription and Affecting the TLR4/MyD88/NF-κB Pathway. | Appl Biochem Biotechnol | 2026 | 41231402 | PubTator, text mining | PubMed |
| Depletion of FOXO4 promotes the development of nonalcoholic fatty liver disease by aggravating high-fat diet-induced liver injury by increasing SPP1 expression. | Arab J Gastroenterol | 2026 | 41224607 | PubTator, text mining | PubMed |
| Aging and lung diseases: Unraveling mechanisms and therapeutic targets. | Chin Med J Pulm Crit Care Med | 2025 | 41551014 | PubTator, text mining | PubMed |
| Evaluation of crizotinib as radiosensitizer in sacral chordoma cells: effects of combined carbon ion particle therapy. | Med Oncol | 2025 | 41442054 | PubTator, text mining | PubMed |
| FLLL31 Induces Apoptosis via the FOXO4/BCL6 Axis to Inhibit Bladder Cancer Progression. | Hum Mutat | 2025 | 41438489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4303/papers?page=2